Related Experiment Video
Updated: Feb 21, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Acute cardiomyopathy with MCAT abuse
Andrew Redfern1, Caroline Sampson1, Marco Giovannelli1
1Northampton General Hospital, Northampton, UK.
This anonymized letter discusses ethical publication standards when patient consent cannot be obtained. It highlights the importance of rigorous review and approval processes for disseminating medical insights.
Area of Science:
- Medical Ethics
- Publication Standards
- Anonymized Case Letters
Background:
- Ethical considerations in medical publishing are paramount.
- Obtaining patient consent for publication can be challenging.
- Anonymization and rigorous review are crucial when direct consent is impossible.
Purpose of the Study:
- To present medical insights in an anonymized format.
- To adhere to Committee on Publication Ethics (COPE) guidelines.
- To justify publication when patient consent is unobtainable.
Main Methods:
- Anonymization of patient data.
- Extensive review by journal editors and external medical journal editors.
- Caldicott Guardian approval obtained from the Trust's Executive Medical Director.
Main Results:
- The manuscript was accepted as a letter, not a case report, due to lack of patient consent.
- All reviewers agreed the imparted message justified anonymized publication.
- Author affiliations are available upon request.
Conclusions:
- Publication of anonymized medical information is permissible under strict ethical oversight.
- Adherence to COPE guidelines and institutional approvals ensures ethical standards.
- Dissemination of important medical messages can be achieved even without direct patient consent.
More Related Videos
09:16Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
Published on: February 28, 2018
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Myocarditis I: Introduction